EGFR and non-small cell lung carcinoma: The frequency of EGFR exon 20 insertion (EGFR ex20ins) mutations in all NSCLC patients has been reported to range from 1% to 10% and approximately 4%–10% of EGFR-mutant NSCLC patients (3–5).